Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43 GBX | -3.80% | -7.53% | -63.09% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 01 | Avacta picks Christina Coughlin to replace long-serving CEO | AN |
Sales 2023 | 23.25M 28.96M | Sales 2024 * | 24.5M 30.52M | Capitalization | 159M 198M |
---|---|---|---|---|---|
Net income 2023 | -24M -29.9M | Net income 2024 * | -27M -33.64M | EV / Sales 2023 | 14 x |
Net cash position 2023 * | 16.2M 20.18M | Net cash position 2024 * | 22.4M 27.9M | EV / Sales 2024 * | 5.57 x |
P/E ratio 2023 |
-12.7
x | P/E ratio 2024 * |
-5.77
x | Employees | 120 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.66% |
Latest transcript on Avacta Group Plc
1 day | -1.83% | ||
1 week | -5.63% | ||
Current month | -4.09% | ||
1 month | -18.36% | ||
3 months | -56.12% | ||
6 months | -69.84% | ||
Current year | -62.33% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
Matt Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 13-09-15 |
Michael Vinegrad
IRO | Public Communications Contact | - | 14-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Nicholls
BRD | Director/Board Member | 67 | 13-08-01 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
Paul Fry
BRD | Director/Board Member | 58 | 20-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 43 | -3.80% | 1 999 037 |
24-05-08 | 44.7 | -0.89% | 3,315,287 |
24-05-07 | 45.1 | -0.88% | 3,413,113 |
24-05-03 | 45.5 | -2.15% | 4,092,357 |
24-05-02 | 46.5 | -0.53% | 2,722,374 |
Delayed Quote London S.E., May 09, 2024 at 06:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-62.33% | 198M | |
+2.93% | 108B | |
-0.82% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- AVCT Stock